Review
doi: 10.6004/jnccn.2018.7081.
Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position
- PMID: 30442738
- DOI: 10.6004/jnccn.2018.7081
Item in Clipboard
Review
Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position
J Natl Compr Canc Netw.
2018 Nov.
Abstract
Breast cancer remains the most common nonskin cancer among women and a leading cause of morbidity and mortality. Early detection through screening and advances in treatment have contributed to a 39% mortality reduction in the United States since 1990. The NCCN Guidelines for Breast Cancer Screening and Diagnosis recommend annual mammographic screening for average-risk women beginning at age 40 years. Mammographic screening and subsequent treatment reduces breast cancer mortality based on a wide range of studies. This article highlights NCCN's position on screening mammography and the screening controversy.
Copyright © 2018 by the National Comprehensive Cancer Network.
Similar articles
-
Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2018 Nov;16(11):1362-1389. doi: 10.6004/jnccn.2018.0083. J Natl Compr Canc Netw. 2018. PMID: 30442736
-
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.Ann Intern Med. 2016 Feb 16;164(4):215-25. doi: 10.7326/M15-1536. Epub 2016 Jan 12. Ann Intern Med. 2016. PMID: 26756606 Free PMC article.
-
Assessing mammography's benefits and harms.J Natl Cancer Inst. 2014 Apr;106(4):dju103. doi: 10.1093/jnci/dju103. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685934 No abstract available.
-
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.Ann Intern Med. 2016 Feb 16;164(4):256-67. doi: 10.7326/M15-0970. Epub 2016 Jan 12. Ann Intern Med. 2016. PMID: 26756737 Review.
-
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.CMAJ. 2001 Feb 20;164(4):469-76. CMAJ. 2001. PMID: 11233866 Free PMC article. Review.
Cited by
-
"It's something I'll do until I die": A qualitative examination into why older women in the U.S. continue screening mammography.Cancer Med. 2022 Oct;11(20):3854-3862. doi: 10.1002/cam4.4758. Epub 2022 May 26. Cancer Med. 2022. PMID: 35616300 Free PMC article.
-
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer.J Immunother Cancer. 2021 Aug;9(8):e002597. doi: 10.1136/jitc-2021-002597. J Immunother Cancer. 2021. PMID: 34389617 Free PMC article.
-
External validation of AI algorithms in breast radiology: the last healthcare security checkpoint?Quant Imaging Med Surg. 2021 Jun;11(6):2888-2892. doi: 10.21037/qims-20-1409. Quant Imaging Med Surg. 2021. PMID: 34079749 Free PMC article. No abstract available.
-
Examining Associations between Source of Cancer Information and Mammography Behavior among Black Church-Going Women.Int J Environ Res Public Health. 2022 Oct 11;19(20):13004. doi: 10.3390/ijerph192013004. Int J Environ Res Public Health. 2022. PMID: 36293643 Free PMC article.
-
Overcoming Barriers in Ductal Carcinoma In Situ Management: From Overtreatment to Optimal Treatment.J Clin Oncol. 2022 Jan 20;40(3):225-230. doi: 10.1200/JCO.21.01674. Epub 2021 Nov 23. J Clin Oncol. 2022. PMID: 34813345 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
